Paediatric Intensive Care Unit, The Royal Children's Hospital, Parkville, VIC, Australia.
Murdoch Children's Research Institute, Parkville, VIC, Australia.
Pediatr Crit Care Med. 2020 Dec;21(12):e1119-e1125. doi: 10.1097/PCC.0000000000002470.
To describe the prevalence and consequences of major adverse events secondary to extubation failure after neonatal cardiac surgery.
A single-center cohort study.
A medical-surgical, 30-bed PICU in Victoria, Australia.
One thousand one hundred eighty-eight neonates less than or equal to 28 days old who underwent cardiac surgery from January 2007 to December 2018.
None.
Extubation failure was defined as unplanned reintubation within 72 hours after a planned extubation. Major adverse event was defined as one or more of cardiac arrest, emergency chest reopening, extracorporeal membrane oxygenation, or death within 72 hours after extubation. One hundred fifteen of 1,188 (9.7%) neonates had extubation failure. Hospital mortality was 17.4% and 2.0% in neonates with and without extubation failure. Major adverse event occurred in 12 of 115 reintubated neonates (10.4%). major adverse event included cardiac arrest (n = 10), chest reopening (n = 8), extracorporeal membrane oxygenation (n = 5), and death (n = 0). Cardiovascular compromise accounted for major adverse event in eight: ventricular dysfunction (n = 3), pulmonary overcirculation (n = 2), coronary ischemia (n = 2), cardiac tamponade (n = 1). In a multivariable logistic regression, factors associated with major adverse event were high complexity in cardiac surgery (odds ratio 5.9; 95% CI: 1.1-32.2) and airway anomaly (odds ratio 6.0; 95% CI: 1.1-32.6). Hospital morality was 25% and 17% in reintubated neonates with and without major adverse event.
Around 10% of reintubated neonates suffered major adverse event within 72 hours of extubation. Neonates suffering major adverse event had high mortality. Major adverse event should be monitored and reported in future studies of extubation failure. Along with tracking of extubation failure rates, major adverse event secondary to extubation failure may also serve as a key performance indicator for ICUs and registries.
描述新生儿心脏手术后拔管失败导致的主要不良事件的发生率和后果。
单中心队列研究。
澳大利亚维多利亚州的一个医疗-外科 30 床 PICU。
2007 年 1 月至 2018 年 12 月期间,1188 名小于或等于 28 天的新生儿接受心脏手术。
无。
拔管失败定义为计划拔管后 72 小时内再次计划性插管。主要不良事件定义为拔管后 72 小时内发生心脏骤停、紧急开胸、体外膜肺氧合或死亡之一或更多。1188 名新生儿中有 115 名(9.7%)发生拔管失败。有和无拔管失败的新生儿的院内死亡率分别为 17.4%和 2.0%。115 名再次插管的新生儿中有 12 名(10.4%)发生主要不良事件。主要不良事件包括心脏骤停(n=10)、开胸(n=8)、体外膜肺氧合(n=5)和死亡(n=0)。心血管功能障碍导致 8 例主要不良事件:室性心功能不全(n=3)、肺过度循环(n=2)、冠状动脉缺血(n=2)、心脏压塞(n=1)。多变量逻辑回归分析显示,与主要不良事件相关的因素有心内直视手术的高复杂性(比值比 5.9;95%CI:1.1-32.2)和气道异常(比值比 6.0;95%CI:1.1-32.6)。再次插管的新生儿中,有和无主要不良事件的院内死亡率分别为 25%和 17%。
大约 10%的再次插管新生儿在拔管后 72 小时内发生主要不良事件。发生主要不良事件的新生儿死亡率较高。在未来的拔管失败研究中,应监测和报告主要不良事件。除了跟踪拔管失败率外,拔管失败引起的主要不良事件也可以作为 ICU 和登记处的关键绩效指标。